Medical

Accuray

$5.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.78%) Today
+$0.25 (+4.82%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Accuray and other stocks, options, and ETFs commission-free!

About ARAY

Accuray Incorporated Common Stock, also called Accuray, is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA. The listed name for ARAY is Accuray Incorporated Common Stock.

CEO
Joshua H. Levine
Employees
932
Headquarters
Sunnyvale, California
Founded
1990
Market Cap
473.71M
Price-Earnings Ratio
35.57
Dividend Yield
—
Average Volume
1.02M
High Today
$5.42
Low Today
$4.95
Open Price
$5.06
Volume
1.80M
52 Week High
$5.42
52 Week Low
$1.33

Collections

ARAY Earnings

-$0.11
-$0.06
-$0.00
$0.05
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.02 per share
Actual
$0.05 per share
Replay Earnings Call

You May Also Like

ROBT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure